A股異動 | 華菱星馬(600375.SH)漲超5% 公司控股股東及實控人變更
格隆匯9月21日丨華菱星馬(600375.SH)現報8.18元,漲5.41%,暫成交1億元,最新總市值45億元。華菱星馬上週五(18日)盤後公佈,星馬集團已將持有的公司全部股份2413.61萬股過户至吉利商用車集團,華神建材已將持有的公司全部股份6054.48萬股過户至吉利商用車集團。本次股份過户登記完成後,星馬集團及華神建材不再持有公司股份,吉利商用車集團持有公司8468.09萬股股份,佔公司總股本的15.24%。公司控股股東由星馬集團變更為吉利商用車集團,公司實際控制人由馬鞍山市人民政府變更為李書福。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.